Mutation of epidermal growth factor receptor gene in adenosquamous carcinoma of the lung

Lung Cancer

Volumn 55, Issue 1, 2007, Pages 129-130

  Sasaki, Hidefumi ^a   Endo, Katsuhiko ^a   Yukiue, Haruhiro ^a   Kobayashi, Yoshihiro ^a   Yano, Motoki ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Adenosquamous; EGFR; Mutation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ANALYSIS; CANCER TISSUE; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HUMAN; INCIDENCE; LETTER; LUNG CARCINOMA; LUNG PARENCHYMA; MALE; PRIORITY JOURNAL; PROTEIN DOMAIN; SEX DIFFERENCE; SMOKING;

AGED; CARCINOMA, ADENOSQUAMOUS; FEMALE; GENES, RAS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 33845920875     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.09.003     Document Type: Letter

References (16)

1. Haneda H., Sasaki H., Shimizu S., Endo K., Suzuki E., Yukiue H., et al. Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung. Lung Cancer 52 (2006) 47-52
2. Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304 (2004) 1497-1500
3. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. New Engl J Med 350 (2004) 2129-2139
4. Sugio K., Uramoto H., Ono K., Oyama T., Hanagiri H., and Sugaya M. Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking. Br J Cancer 94 (2006) 896-903
5. Travis W.D., Branbilla E., Muller Hermelink H.K., and Harris H.H. World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC (2004) 10-54
6. Niho S., Yokose T., Kodama T., Nishiwaki Y., and Mukai K. Clonal analysis of adenosquamous carcinoma of the lung. Jpn J Cancer Res 90 (1999) 1244-1247
7. Kanazawa H., Ebina M., Ino-Oka N., Shimizukawa M., Takahashi T., Fujimura S., et al. Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung. Am J Pathol 156 (2000) 1289-1298
8. Graziano S.L., Gamble G.P., Newman N.B., Abbott L.Z., Rooney M., Mookherjee S., et al. Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer. J Clin Oncol 17 (1999) 668-675
9. Toyooka S., Yatabe Y., Tokumo M., Ichimura K., Asano H., Tomii K., et al. Mutations of epidermal growth factor receptor and K-ras genes in adenosquamous carcinoma of the lung. Int J Cancer 118 (2006) 1588-1590
10. Naunheim K.S., Taylor S.R., Shosey C., Hoffman P.C., Ferguson M.K., Golomb H.M., et al. Adenosquamous lung carcinoma: clinical characteristics, treatment, and prognosis. Ann Thorac Surg 44 (1987) 462-466
11. Shimizu J., Oda M., Hayashi Y., Nonomura A., and Watanabe Y. A clinico-pathologic study of resected cases of adenosquamous carcinima of lung. Chest 109 (1996) 989-994
12. Sasaki H., Endo K., Konishi A., Takada M., Kawahara M., Iuchi K., et al. EGFR mutation status in Japanese lung cancer patients: genotyping analysis using Lighy Cycler. Clin Cancer Res 11 (2005) 2924-2929
13. Endo K., Konishi A., Sasaki H., Takada M., Tanaka H., Okumura M., et al. Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay. Lung Cancer 50 (2005) 375-384
14. Sasaki H., Shimizu S., Endo K., Takada M., Kawahara M., Tanaka H., et al. EGFR and erbB2 mutation status in Japanese lung cancer patients. Int J Cancer 118 (2006) 180-184
15. Mitsudomi T., Kosaka T., Endoh H., Horio Y., Hida T., Mori S., et al. Mutation of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence. J Clin Oncol 23 (2005) 2513-2520
16. Sasaki H., Endo K., Mizuno K., Yano M., Fukai I., Yamakawa Y., et al. GFR mutation status and prognosis for gefitinib treatment in Japanese lung cancer. Lung Cancer 51 (2006) 135-136